Macitentan

CAS 441798-33-0 14 current recordsSmall Molecule

Who holds supplier records for Macitentan? 14 organisations hold a current record for Macitentan: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (8), China (5) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Macitentan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/macitentan

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Macitentan expires 18 Oct 2029. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Macitentan. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Alembic Pharmaceuticals Limited
    Active DMF 31664 · latest filing Apr 2017
    India Company GMP cert on record
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 31749 · latest filing May 2017
    India Company GMP cert on record
  • HONOUR LAB LTD
    Active DMF 31213 · latest filing Jan 2017
    India Company GMP cert on record
  • Laurus Labs Limited
    Active DMF 31957 · latest filing Sept 2017
    India Company GMP cert on record
  • MATRIX PHARMACORP PRIVATE LTD
    Active DMF 30969 · latest filing Sept 2016
    India
  • MSN LIFE SCIENCES PRIVATE LIMITED
    Active DMF 30212 · latest filing Jan 2016
    India Company GMP cert on record
  • RAKS PHARMA PVT LTD
    Active DMF 31179 · latest filing Dec 2016
    India
  • SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD
    Active DMF 31658 · latest filing May 2017
    China
  • TAPI NL BV
    Active DMF 31416 · latest filing Apr 2017
    Netherlands
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
    Active DMF 41152 · latest filing Apr 2025
    China Company GMP cert on record
  • ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (No. 36 Kangyang Avenue)
    Active DMF 39273 · latest filing Dec 2023
    China
  • Zhejiang Huayi Pharmaceutical Co., Ltd.
    Active DMF 39288 · latest filing Feb 2024
    China
  • ZHEJIANG XIANFENG TECHNOLOGY GROUP CO LTD
    Active DMF 41444 · latest filing Mar 2025
    China
  • Zydus Lifesciences Limited
    Active DMF 31463 · latest filing Apr 2017
    India Company GMP cert on record
Need Macitentan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (13 listed products contain Macitentan). The latest listed patent expires 18 Oct 2029. The latest listed exclusivity runs to 28 Aug 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Macitentan is an endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension (PAH). It works by preventing the vasoconstriction and proliferation effects of endothelin-1, a potent vasoconstrictor.

Chemical identity

IUPAC name
5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine
Canonical SMILES
CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
InChIKey
JGCMEBMXRHSZKX-UHFFFAOYSA-N
Synonyms
Opsumit API, act 064992, act-064992, opsynvi component macitentan, opsumit

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Endothelin Receptor Antagonist
Mechanism of action
Endothelin Receptor Antagonists

Therapeutic areas

Pulmonary Arterial HypertensionCardiovascular Diseases

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Macitentan?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Macitentan: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), HONOUR LAB LTD (India), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), RAKS PHARMA PVT LTD (India) and SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Macitentan Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 31664), APITORIA PHARMA PRIVATE LTD (DMF 31749), HONOUR LAB LTD (DMF 31213), Laurus Labs Limited (DMF 31957), MATRIX PHARMACORP PRIVATE LTD (DMF 30969), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 30212), RAKS PHARMA PVT LTD (DMF 31179) and SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD (DMF 31658) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does the FDA Orange Book list patents for products containing Macitentan?

Yes. The latest patent listed for an approved US product containing Macitentan expires 18 Oct 2029, across 13 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Macitentan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Macitentan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.